Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Early Administration of Heparin at First Medical Contact for PPCI of STEMI PatientsThe goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).
- HELIOS-B Analyses: Vutrisiran Significantly Affects Biomarkers, Echocardiographic ParametersTwo post-hoc analyses of the HELIOS-B trial published Aug. 4 in JACC found that vutrisiran had significant effect on both biomarkers like NT-proBNP and troponin I levels and echocardiographic measures of biventricular systolic and diastolic function in patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM). Furthermore, both these biomarkers and echocardiographic measures provide critical prognostic information.
- FDA Update: Boston Scientific Warns of WATCHMAN Access System IssueThe U.S. Food and Drug Administration (FDA) has announced that certain WATCHMAN Access Systems have updated use instructions to address risk of air embolism.
- ACCEL Lite: LAAO vs. DOAC for Stroke Prevention in AFibIn this interview, Drs. Anthony N. DeMaria and Dhanunjaya Lakkireddy explore the evolving landscape of stroke prevention in patients with atrial fibrillation, focusing on the comparison between traditional blood thinners and LAAO.
- Cardiovascular Care of the Pediatric Athlete: A Timely Guide in Leveling the Playing Field for Young AthletesThe JACC state-of-the-art review on the Cardiovascular Care of the Pediatric Athlete is a comprehensive and timely guide for providers managing cardiovascular (CV) health in pediatric athletes, defined as individuals 5-17 years of age who participate in organized and recreational sports.